Pharmacokinetics of Oral and Extended-release Naltrexone in Pregnant and Lactating Individuals and their Infants
While limited due to sample size, these data provide valuable information about the pharmacokinetics of prenatal use of naltrexone and perinatal transfer, guiding counseling and clinical management of the parent-infant dyad.
Authors
- Mark Mirochnick (ORCID: https://orcid.org/0000-0002-3600-1502)
- Hendrée E. Jones (ORCID: https://orcid.org/0000-0001-6180-8642)
- Raymond T. Suhandynata (ORCID: https://orcid.org/0000-0002-4767-7639)
- Jeremiah D. Momper (ORCID: https://orcid.org/0000-0002-3154-6685)
- Kelley Saia (ORCID: https://orcid.org/0000-0001-9198-5295)
- Martha M. Werler (ORCID: https://orcid.org/0000-0003-3392-6814)
- Nicole Iannella
- Elisha M. Wachman (ORCID: https://orcid.org/0000-0001-9742-2434)
Publication Details
- Journal
- Journal of Addiction Medicine
- Published
- 2025-05-19
- DOI
- https://doi.org/10.1097/adm.0000000000001512
- Primary Topic
- Prenatal Substance Exposure Effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00